• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Agriculture

Engineered Yeast Lysate Enriched With Squalene Attenuates Acute Colitis in Mice

by
November 16, 2026
in Agriculture
Reading Time: 6 mins read
0
Engineered Yeast Lysate Enriched With Squalene Attenuates Acute Colitis in Mice

Engineered Yeast Lysate Enriched With Squalene Attenuates Acute Colitis in Mice

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Metabolically engineered yeast biomass enriched with squalene significantly mitigated colonic pathology, systemic inflammation, and metabolic disruption in a murine model of acute intestinal injury. In a study published in the Journal of Agriculture and Food Research, researchers engineered the budding yeast Saccharomyces cerevisiae to redirect intracellular metabolic flux toward squalene accumulation. They evaluated the bioactivity of the resulting disrupted biomass in male C57BL/6N mice exposed to dextran sulfate sodium. Intragastric administration of the squalene-enriched lysate attenuated hallmark symptoms of chemical colitis, including body weight loss, elevated disease activity, splenomegaly, and colon shortening. The intervention outperformed equivalent doses of parental yeast lysate lacking elevated squalene titers. Biochemical evaluations demonstrated significant reductions in circulating pro-inflammatory mediators, improvements in antioxidant reserves, restoration of depleted fecal short-chain fatty acids, and remodeling of the fecal metabolome. These findings suggest that metabolically modified single-cell protein platforms can deliver bioactive secondary metabolites to support gut homeostasis under acute inflammatory challenge.

The motivation for engineering bioactive yeast biomass stems from pressures on traditional agricultural supply chains. Worldwide population growth, projected to reach 9.7 billion by 2050, drives demand for high-quality animal-derived protein. Conventional feedstuffs like soybean meal and fish meal face constraints including volatile pricing, supply instability, and environmental footprints. International bans on antibiotic growth promoters have ushered livestock production into an antibiotic-free era, increasing vulnerability to intestinal inflammation and mucosal barrier breakdown. Yeast biomass offers a single-cell protein alternative with 40% to 50% crude protein, rapid cultivation, and minimal land and water footprints. Beyond macronutrition, yeast cells contain polysaccharides, nucleotides, and peptides that support gut barrier function and immune regulation. To enhance functional bioactivity, the team targeted squalene biosynthesis, a triterpenoid associated with mucosal barrier protection, anti-inflammatory, and antioxidant properties.

Within Saccharomyces cerevisiae, squalene is synthesized via the mevalonate pathway. The enzyme squalene synthase, encoded by the ERG9 gene, catalyzes the conversion of farnesyl pyrophosphate into squalene. Downstream, squalene epoxidase, encoded by the ERG1 gene, converts squalene into 2,3-oxidosqualene for ergosterol biosynthesis, creating a competing flux that limits squalene accumulation. The researchers utilized an farnesyl pyrophosphate-overproducing chassis strain designated YOS1. Using CRISPR-Cas9 genome-editing vectors, they integrated an ERG9 expression cassette into the 1021b genomic locus to generate strain YOS2. Gas chromatography with flame ionization detection confirmed that ERG9 overexpression elevated the squalene fermentation titer from 266 milligrams per liter in YOS1 to 1075 milligrams per liter in YOS2, while increasing dry cell weight.

To restrict squalene consumption without arresting growth, the investigators engineered promoter-replacement strains derived from YOS2. They substituted the native ERG1 promoter with weaker constitutive or inducible alternatives, evaluating pREV1, pSAC6, pATP3, pGAL7, and pGAL2 to generate strains YOS5 through YOS9. Shake-flask screening revealed that strains harboring pREV1 (YOS5) and pGAL2 (YOS9) achieved squalene titers of 1415.7 and 1226.1 milligrams per liter, respectively. The pREV1 substitution in YOS5 provided the highest titer among tested strains with a slight reduction in dry cell weight, indicating a favorable balance between squalene accumulation and cellular fitness. The authors noted that ERG1 transcript abundance, ergosterol concentrations, and detailed growth kinetics were not quantified in these strains.

To obtain sufficient squalene concentrations for animal interventions, the researchers optimized fermentation conditions for strain YOS5. An inoculation ratio of 16 percent volume-by-volume supported a squalene titer of 1441.3 milligrams per liter. Galactose supplied as the sole carbon source at 40 grams per liter yielded 1444 milligrams per liter, outperforming binary mixtures that yielded higher biomass but lower squalene titers due to carbon catabolite repression. Elevating galactose to 80 grams per liter reached 2298.3 milligrams per liter. Optimizing the organic nitrogen source revealed that a one-to-one mass ratio of yeast extract to peptone at 40 grams per liter increased titers to 2414.0 milligrams per liter. Supplementation with 0.2 grams per liter of manganese sulfate or calcium chloride further boosted titers to 2681.5 and 2634.1 milligrams per liter, respectively. An L9 orthogonal array identified the optimal combination as 40 grams per liter of total organic nitrogen, 0.2 grams per liter of manganese sulfate, and 0.2 grams per liter of calcium chloride, establishing a peak squalene fermentation titer of 3062.20 milligrams per liter.

Preliminary trials indicated that intact yeast cells offered limited protection against chemically induced gut inflammation, leading the team to process biomass into disrupted whole-cell lysates. Pellets from YOS5 and the parental YOS1 chassis were harvested, washed, resuspended to 15.3 percent of the original volume, and homogenized at 80 to 100 megapascals. The squalene content was standardized to deliver 0.4 grams per kilogram of mouse body weight. Male C57BL/6N mice were randomized into four groups of eight: a normal control, a dextran sulfate sodium colitis group, an FPP parental chassis lysate group, and an REC squalene-enriched lysate group. Acute colitis was induced from day four to day eight using three percent dextran sulfate sodium in drinking water, followed by regular water through day eleven, while daily oral gavage continued.

Clinical and anatomical assessments confirmed that squalene-enriched lysate attenuated colitis manifestations. Untreated colitis mice exhibited body weight loss and elevated disease activity index scores. The squalene-enriched lysate maintained higher body weights and reduced disease activity scores compared to the parental lysate. The intervention blunted splenomegaly and preserved colon length close to healthy controls, whereas the parental lysate produced limited corrections. Histopathological scoring of hematoxylin and eosin-stained colon sections showed that severe mucosal erosion and inflammatory infiltration were significantly ameliorated in REC-treated mice, yielding lower injury scores than the FPP chassis cohort.

Alcian blue-periodic acid-Schiff staining demonstrated that the squalene-enriched lysate preserved colonic mucosal architecture and goblet cell capacity. Normal controls displayed intact crypts and abundant goblet cells, while untreated colitis mice exhibited crypt distortion and goblet cell depletion. The parental lysate achieved partial preservation of crypt structures, but mucus layer fragmentation remained widespread. In contrast, mice receiving squalene-enriched lysate showed organized crypt arrangements, restored goblet cell numbers, and continuous mucus coatings, confirming preservation of physical and biochemical barriers.

Biochemical profiling highlighted systemic antioxidant and anti-inflammatory effects. Dextran sulfate sodium induction reduced serum total superoxide dismutase activity by 49.96 percent and glutathione concentrations by 11.28 percent. Oral administration of REC lysate increased total superoxide dismutase activity by 51.43 percent, raised glutathione levels by 17.92 percent, and decreased malondialdehyde concentrations by 9.74 percent relative to the untreated colitis cohort. The parental lysate produced no statistically significant changes in these markers. The chemical challenge significantly elevated C-reactive protein and tumor necrosis factor-alpha. REC lysate reduced C-reactive protein by 59.12 percent and tumor necrosis factor-alpha by 20.58 percent, while interleukin-1-beta declined numerically by 6.57 percent without statistical significance. Conversely, mice receiving parental lysate exhibited significant elevations in C-reactive protein, tumor necrosis factor-alpha, and interleukin-1-beta compared to untreated colitis mice.

Gas chromatographic quantification revealed that squalene-enriched lysate restored microbial metabolic outputs compromised by inflammation. Dextran sulfate sodium depleted fecal acetate to 21.18 percent of healthy control levels, alongside reductions in propionate and butyrate. REC lysate partially restored these acids, bringing butyrate, propionate, and acetate to 16.57 percent, 55.57 percent, and 40.88 percent of normal baseline concentrations, respectively. The parental lysate recovered butyrate and acetate to 10.80 percent and 31.75 percent of control values. The authors suggested that yeast components provided fermentable substrates, while squalene enrichment aided metabolic recovery. However, without microbial taxonomy profiling, specific bacterial communities responsible for fatty acid recovery could not be identified.

Untargeted liquid chromatography-tandem mass spectrometry profiling provided an overview of global metabolic perturbations. Principal component analysis and orthogonal partial least-squares discriminant analysis showed clear separation between healthy controls and colitis animals. The REC group profile shifted away from the colitis cluster and positioned closest to the normal control group. Chemical colitis caused depletion of glycerophospholipids, including phosphatidylcholine, phosphatidic acid, and lysophosphatidylethanolamine, alongside elevations in L-2-hydroxyglutaric acid. REC lysate reversed the accumulation of L-2-hydroxyglutaric acid and altered abundances of bile acid derivatives and gamma-glutamylcysteine. Pathway enrichment analysis linked these metabolites to histidine, propanoate, and biotin metabolism, corroborating improvements in short-chain fatty acid levels and antioxidant capacity.

The study authors noted several methodological limitations. The in vivo investigation tested only a single exploratory dosage of 400 milligrams of squalene per kilogram of body weight over an acute eleven-day protocol, leaving the dose-response relationship uncharacterized. The design did not include a purified squalene control or comprehensive compositional profiling of the lysates, preventing attribution of benefits exclusively to squalene. The lack of gut microbiota sequencing prevents establishing causal links between specific bacterial taxa and metabolic restoration. Finally, the acute murine model does not capture the complexities of chronic conditions or long-term safety. Future research incorporating microbiome sequencing, purified controls, multi-dose regimens, and biosafety trials in production animals is required before commercial deployment.

Subject of Research: Metabolic engineering of yeast for squalene enrichment and its intestinal protective effects in murine colitis

Article Title: Metabolic engineering of Saccharomyces cerevisiae for squalene-enriched biomass production and evaluation of the protective effects of its lysate against DSS-induced colitis

Article References: Wan, S., Zou, L., Jin, Z., Dong, W., Zhang, Y., Ke, L., Mei, Y., Chen, Y., & Hu, Y. (2026). Metabolic engineering of Saccharomyces cerevisiae for squalene-enriched biomass production and evaluation of the protective effects of its lysate against DSS-induced colitis. Journal of Agriculture and Food Research, 32, Article 103432. https://doi.org/10.1016/j.jafr.2026.103432

Image Credits: AI Generated

DOI: 10.1016/j.jafr.2026.103432

Keywords: Saccharomyces cerevisiae, squalene biosynthesis, metabolic engineering, yeast lysate, dextran sulfate sodium, murine colitis, intestinal mucosal barrier, ERG9 overexpression, ERG1 promoter replacement, short-chain fatty acids, untargeted fecal metabolomics, oxidative stress markers, pro-inflammatory cytokines, single-cell protein, functional feed additives, farnesyl pyrophosphate

News Source: Alan Morgan. (November 16, 2026). Engineered Yeast Lysate Enriched With Squalene Attenuates Acute Colitis in Mice. Scienmag.

Tags: dextran sulfate sodiumERG1 promoter replacementERG9 overexpressionfarnesyl pyrophosphatefunctional feed additivesintestinal mucosal barrierMetabolic engineeringmurine colitisoxidative stress markerspro-inflammatory cytokinesSaccharomyces cerevisiaeshort-chain fatty acidssingle-cell proteinsqualene biosynthesisuntargeted fecal metabolomicsyeast lysate
Share12Tweet7Share2ShareShareShare1

Related Posts

CRISPR Knockout of NbRbohC1 Enhances Recombinant Protein Yield in Tobacco Leaves

CRISPR Knockout of NbRbohC1 Enhances Recombinant Protein Yield in Tobacco Leaves

November 19, 2026
Timely Drip Irrigation Within Three Days After Sowing Increases Maize Yield

Timely Drip Irrigation Within Three Days After Sowing Increases Maize Yield

November 19, 2026

Industrial Specialization Enhances Agricultural Green Production Efficiency Across Chinese Cities

November 19, 2026

Seed-to-Seed Techniques and Vernalization Maximize Tropical Botanical Shallot Seed Yields

November 18, 2026

POPULAR NEWS

  • Electrical Nerve Stimulation Reduces Acute Postoperative Pain Following Knee Replacement

    Electrical Nerve Stimulation Reduces Acute Postoperative Pain Following Knee Replacement

    29 shares
    Share 12 Tweet 7
  • Thermodynamic Kinetic Modeling Unifies Ammonia Desorption Across Titanium Silicalite-1 Zeolites

    29 shares
    Share 12 Tweet 7
  • Elevated Waist-to-Height Ratio and HbA1c Linked to Higher Cardiovascular Disease Risk

    29 shares
    Share 12 Tweet 7
  • Silver-Functionalized Chitosan Nanoparticles Enhance Platelet-Rich Plasma for Canine Wound Healing

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Medical and Dental Students Use FOAMed to Fill Classroom Learning Gaps

Bowel Cancer Stool Tests May Require Tailored Cut-Offs for Younger Patients

Orange-Red Samarium-Doped Calcium Yttrium Oxide Phosphors Advance Solid-State Lighting

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.